236 related articles for article (PubMed ID: 16817764)
1. Induction of antigen-specific immune responses in vivo after vaccination with dendritic cells transduced with adenoviral vectors encoding hepatitis C virus NS3.
Xiang M; Eisenbach C; Lupu CM; Ernst E; Stremmel W; Encke J
Viral Immunol; 2006; 19(2):210-9. PubMed ID: 16817764
[TBL] [Abstract][Full Text] [Related]
2. Enhanced T cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cells.
Echeverria I; Pereboev A; Silva L; Zabaleta A; Riezu-Boj JI; Bes M; Cubero M; Borras-Cuesta F; Lasarte JJ; Esteban JI; Prieto J; Sarobe P
Hepatology; 2011 Jul; 54(1):28-37. PubMed ID: 21452282
[TBL] [Abstract][Full Text] [Related]
3. Vaccination against hepatitis C virus with dendritic cells transduced with an adenovirus encoding NS3 protein.
Zabaleta A; Llopiz D; Arribillaga L; Silva L; Riezu-Boj JI; Lasarte JJ; Borrás-Cuesta F; Prieto J; Sarobe P
Mol Ther; 2008 Jan; 16(1):210-7. PubMed ID: 17923840
[TBL] [Abstract][Full Text] [Related]
4. Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain.
Mikkelsen M; Holst PJ; Bukh J; Thomsen AR; Christensen JP
J Immunol; 2011 Feb; 186(4):2355-64. PubMed ID: 21257961
[TBL] [Abstract][Full Text] [Related]
5. Priming with two DNA vaccines expressing hepatitis C virus NS3 protein targeting dendritic cells elicits superior heterologous protective potential in mice.
Guan J; Deng Y; Chen H; Yin X; Yang Y; Tan W
Arch Virol; 2015 Oct; 160(10):2517-24. PubMed ID: 26215441
[TBL] [Abstract][Full Text] [Related]
6. Induction of potent cellular immune response in mice by hepatitis C virus NS3 protein with double-stranded RNA.
Jin B; Wang RY; Qiu Q; Sugauchi F; Grandinetti T; Alter HJ; Shih JW
Immunology; 2007 Sep; 122(1):15-27. PubMed ID: 17451465
[TBL] [Abstract][Full Text] [Related]
7. Humoral and CD4(+) T helper (Th) cell responses to the hepatitis C virus non-structural 3 (NS3) protein: NS3 primes Th1-like responses more effectively as a DNA-based immunogen than as a recombinant protein.
Lazdina U; Hultgren C; Frelin L; Chen M; Lodin K; Weiland O; Leroux-Roels G; Quiroga JA; Peterson DL; Milich DR; Sällberg M
J Gen Virol; 2001 Jun; 82(Pt 6):1299-1308. PubMed ID: 11369873
[TBL] [Abstract][Full Text] [Related]
8. Priming with CpG-enriched plasmid and boosting with protein formulated with CpG oligodeoxynucleotides and Quil A induces strong cellular and humoral immune responses to hepatitis C virus NS3.
Yu H; Babiuk LA; van Drunen Littel-van den Hurk S
J Gen Virol; 2004 Jun; 85(Pt 6):1533-1543. PubMed ID: 15166437
[TBL] [Abstract][Full Text] [Related]
9. Immunization against hepatitis C virus with a fusion protein containing the extra domain A from fibronectin and the hepatitis C virus NS3 protein.
Mansilla C; Gorraiz M; Martinez M; Casares N; Arribillaga L; Rudilla F; Echeverria I; Riezu-Boj JI; Sarobe P; Borrás-Cuesta F; Prieto J; Lasarte JJ
J Hepatol; 2009 Sep; 51(3):520-7. PubMed ID: 19596480
[TBL] [Abstract][Full Text] [Related]
10. Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus.
Arribillaga L; de Cerio AL; Sarobe P; Casares N; Gorraiz M; Vales A; Bruna-Romero O; Borrás-Cuesta F; Paranhos-Baccala G; Prieto J; Ruiz J; Lasarte JJ
Vaccine; 2002 Dec; 21(3-4):202-10. PubMed ID: 12450695
[TBL] [Abstract][Full Text] [Related]
11. The functional evaluation of dendritic cell vaccines based on different hepatitis C virus nonstructural genes.
Tian Y; Zhang HH; Wei L; Du SC; Chen HS; Fei R; Liu F
Viral Immunol; 2007 Dec; 20(4):553-61. PubMed ID: 18158729
[TBL] [Abstract][Full Text] [Related]
12. Monocyte-derived dendritic cells from HCV-infected patients transduced with an adenovirus expressing NS3 are functional when stimulated with the TLR3 ligand poly(I:C).
Echeverría I; Zabaleta A; Silva L; Díaz-Valdés N; Riezu-Boj JI; Lasarte JJ; Borrás-Cuesta F; Civeira MP; Prieto J; Sarobe P
J Viral Hepat; 2008 Nov; 15(11):782-9. PubMed ID: 18637068
[TBL] [Abstract][Full Text] [Related]
13. [Immunogenicity and heterologous protection in mice with a recombinant adenoviral-based vaccine carrying a hepatitis C virus truncated NS3 and core fusion protein].
Guan J; Deng Y; Chen H; Yang Y; Wen B; Tan W
Bing Du Xue Bao; 2015 Jan; 31(1):7-13. PubMed ID: 25997323
[TBL] [Abstract][Full Text] [Related]
14. Vaccination with protein-transduced dendritic cells elicits a sustained response to hepatitis C viral antigens.
Kuzushita N; Gregory SH; Monti NA; Carlson R; Gehring S; Wands JR
Gastroenterology; 2006 Feb; 130(2):453-64. PubMed ID: 16472599
[TBL] [Abstract][Full Text] [Related]
15. Recombinant adenoviral vector expressing HCV NS4 induces protective immune responses in a mouse model of Vaccinia-HCV virus infection: a dose and route conundrum.
Singh S; Vedi S; Li W; Samrat SK; Kumar R; Agrawal B
Vaccine; 2014 May; 32(23):2712-21. PubMed ID: 24631092
[TBL] [Abstract][Full Text] [Related]
16. [The combined application of nucleotide and amino acid sequences of NS3 hepatitis C virus protein, DNA encoding granulocyte macrophage colony-stimulating factor and inhibitor of regulatory T cells induces effective immune response against hepatitis C virus].
Masalova OV; Lesnova EI; Shingarova LN; Tunitskaia VL; Ulanova TI; Burkov AN; Kushch AA
Mol Biol (Mosk); 2012; 46(3):525-34. PubMed ID: 22888642
[TBL] [Abstract][Full Text] [Related]
17. Genetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen.
Martin P; Parroche P; Chatel L; Barretto C; Beck A; Trépo C; Bain C; Lone YC; Inchauspé G; Fournillier A
J Med Virol; 2004 Nov; 74(3):397-405. PubMed ID: 15368525
[TBL] [Abstract][Full Text] [Related]
18. Enhanced hepatitis C virus NS3 specific Th1 immune responses induced by co-delivery of protein antigen and CpG with cationic liposomes.
Jiao X; Wang RY; Qiu Q; Alter HJ; Shih JW
J Gen Virol; 2004 Jun; 85(Pt 6):1545-1553. PubMed ID: 15166438
[TBL] [Abstract][Full Text] [Related]
19. HCV-NS3 Th1 minigene vaccine based on invariant chain CLIP genetic substitution enhances CD4(+) Th1 cell responses in vivo.
Gao M; Wang HP; Wang YN; Zhou Y; Wang QL
Vaccine; 2006 Jun; 24(26):5491-7. PubMed ID: 16725235
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cells pulsed with hepatitis C virus NS3 protein induce immune responses and protection from infection with recombinant vaccinia virus expressing NS3.
Yu H; Huang H; Xiang J; Babiuk LA; van Drunen Littel-van den Hurk S
J Gen Virol; 2006 Jan; 87(Pt 1):1-10. PubMed ID: 16361412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
